Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/VAL stock hub

AIM/VAL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/VALis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/VAL
In the news

Latest news · AIM/VAL

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-57.7
P25 -54.2P50 2.1P75 13.7
ROIC-38.6
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/VAL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
GBP
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
14
Employees Change
-2%
Employees Change Percent
-12.5
Enterprise value
GBX 1M
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Biotechnology
Isin
GB00BLH13C52
Last refreshed
2026-05-10
Market cap
GBX 2M
Price
GBX 0.28
Price currency
GBX
Rev Per Employee
3,555.36x
Sector
Healthcare
Sic
2836
Symbol
aim/VAL
Website
https://www.valirx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-90.59%
EV Earnings
-0.57x
EV/FCF
-0.6x
EV/Sales
20.42x
FCF yield
-85.63%
P/B ratio
0.65x
P/S ratio
39.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
Gross margin
100%
Gross Profit
GBX 49,775
Gross Profit Growth
0%
Gross Profit Growth3 Y
82.71%
Net Income
GBX -1.8M
Net Income Growth Quarters
3%
Net Income Growth Years
2%
Pretax Margin
-4,037.34%
Profit Per Employee
GBX -127,373
ROA
-37.13
Roa5y
-33.76
ROCE
-66.99
ROE
-57.69
Roe5y
-53.68
ROIC
-38.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-56.85%
Cagr15y
-50.23%
Cagr1y
-49.11%
Cagr3y
-69.37%
Cagr5y
-57.98%
EPS Growth Quarters
4
EPS Growth Years
2
Revenue Growth
418.49x
Revenue Growth Quarters
1x
Revenue Growth Years
1x
Revenue Growth3 Y
73.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
GBX 0.01
Assets
GBX 3.1M
Cash
GBX 518,794
Current Assets
GBX 844,581
Current Liabilities
GBX 87,447
Debt
GBX 6,661
Debt Equity
GBX 0
Debt FCF
GBX -0
Equity
GBX 3M
Interest Coverage
-638.7
Liabilities
GBX 87,447
Long Term Assets
GBX 2.3M
Long Term Liabilities
GBX 0
Net Cash
GBX 512,133
Net Cash By Market Cap
GBX 26.02
Net Cash Growth
-35.35%
Net Debt Equity
GBX -0.17
Tangible Book Value
GBX 1.4M
Tangible Book Value Per Share
GBX 0
WACC
1.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
9.66
Net Working Capital
GBX 245,001
Quick ratio
8.87
Working Capital
GBX 757,134
Working Capital Turnover
GBX 0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-116.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-99.98%
1Y total return
-49.09%
200-day SMA
0.41
3Y total return
-97.13%
50-day SMA
0.3
50-day SMA vs 200-day SMA
50under200
5Y total return
-98.69%
All Time High
820,402.2
All Time High Change
-100%
All Time High Date
2006-10-06
All Time Low
0.22
All Time Low Change
27.27%
All Time Low Date
2025-10-30
ATR
0.02
Beta
-0.56
Beta1y
-0.15
Beta2y
0.13
Ch YTD
-16.42
High
0.28
High52
0.88
High52 Date
2025-06-20
High52ch
-68%
Low
0.28
Low52
0.22
Low52 Date
2025-11-24
Low52ch
27.27%
Ma50ch
-7.35%
Price vs 200-day SMA
-31.79%
RSI
24.52
RSI Monthly
32.82
RSI Weekly
34.96
Sharpe ratio
-0.29x
Sortino ratio
-0.34
Total Return
-116.98%
Tr YTD
-16.42
Tr15y
-100%
Tr1m
-3.45%
Tr3m
-18.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
GBX -2M
Operating margin
-4,053.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
665,581,204%
Net Borrowing
-10,334
Shares Insiders
10.31%
Shares Institutions
80.73%
Shares Out
742,801,072
Shares Qo Q
182.84%
Shares Yo Y
116.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
GBX -1.7M
Average Volume
1,690,153.75x
Bv Per Share
0.01
CAPEX
GBX -21,237
Ch10y
-99.98
Ch15y
-100
Ch1m
-3.45
Ch1y
-49.09
Ch3m
-18.84
Ch3y
-97.13
Ch5y
-98.69
Ch6m
19.15
Change
5.66%
Change From Open
0
Close
0.27
Days Gap
5.66
Depreciation Amortization
254,425
Dollar Volume
422,962.7
Earnings Date
2026-05-05
EBIT
GBX -2M
EBITDA
GBX -1.8M
EPS
GBX -0.01
F Score
3
FCF
GBX -1.7M
FCF EV Yield
-165.83x
FCF Per Share
GBX -0
Financing CF
1,395,188
Fiscal Year End
December
Founded
2,000
Goodwill
1,602,522
Income Tax
GBX -129,907
Investing CF
-21,237
Is Primary Listing
1
Last Earnings Date
2026-01-09
Last Report Date
2025-06-30
Last Split Date
2020-04-06
Last Split Type
Reverse
Ma150
0.34
Ma150ch
-18.32%
Ma20
0.29
Ma20ch
-1.93%
Net CF
-290,353
Open
0.28
Ppne
169,830
Price Date
2026-05-08
Ptbv Ratio
1.41
Relative Volume
0.89x
Revenue
49,775x
SBC By Revenue
-38.16x
Share Based Comp
-18,994
Tax By Revenue
-260.99x
Tr6m
19.15%
Volume
1,510,581
Z Score
-3.41
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/VAL pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/VAL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-49.1%
S&P 500 1Y: n/a
3Y total return
-97.1%
S&P 500 3Y: n/a
5Y total return
-98.7%
S&P 500 5Y: n/a
10Y total return
-100.0%
S&P 500 10Y: n/a
Ownership

Who owns AIM/VAL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+80.7%
Share of float held by funds and institutions
Insider ownership
+10.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+117.0%
Negative means the company is buying back shares.
Technical

AIM/VAL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
24.5
Below 30: short-term oversold
Price vs 200-day MA
-31.8%
50/200-day relationship not available
Beta (5Y)
-0.56
Less volatile than the market
Sharpe ratio
-0.29
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/VAL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/VAL stock rating?

aim/VAL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/VAL analysis?

The full report lives at /stocks/aim/VAL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/VAL?

The latest report frames aim/VAL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/VAL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.